ZM 447439

ZM 447439は、オーロラ選択ATPです-競争的な阻害剤で、オーロラAキナーゼとオーロラBキナーゼに作用すると、IC50が それぞれ 110 nM と 130 nM,になる。

目録号S1103
5 5 3レビュー 9製品表彰状
価格 在庫  
USD 88 In stock
USD 123 In stock
USD 138 In stock
USD 340 In stock
USD 592 In stock

ZM 447439 化学構造
分子量: 513.59

品質と確認

カスタマーレビュー(3)

Quality Control & MSDS

製品情報

  • Compare Aurora Kinase Inhibitors
    Aurora Kinase阻害剤を比較
  • 研究分野
  • ZM 447439のメカニズム

製品の説明

生物活性

情報 ZM 447439は、オーロラ選択ATPです-競争的な阻害剤で、オーロラAキナーゼとオーロラBキナーゼに作用すると、IC50が それぞれ 110 nM と 130 nM,になる。
目標 Aurora A Aurora B
IC50 110 nM 130 nM [1]
In vitro試験 In vitro, ZM-447439 selectively inhibits recombinant human Aurora A and B with IC50 values of 110 and 130 nM, respectively, while other protein kinases of diverse structural types including the mitotic kinases CDK1 and PLK1 are inhibited with IC50 values >10 μM. [1] Aurora kinase inhibitor, ZM-447439 time- and dose-dependently inhibits the growth of all three cell lines with IC50 values of 3 μM (BON), 0.9 μM (QGP-1) and 3 μM (MIP-101) after 72 hours of continuous exposure. In addition, ZM-447439 potently induces cell apoptosis by promoting DNA fragmentation and caspase 3 and 7 activation, and arrests GEP-NET cells in the G0 /G1and G2/M phase of the cell cycle. [2] In mouse embryo, inhibition of Aurora kinase activity by ZM-447439 results in abnormalities during mitosis by regulating the phosphorylation of histone H3 serine 10 (H3S10Ph) from G2 to metaphase with different perturbations in each embryonic cycle. [3] A recent study shows that ZM-447439 exhibits growth inhibitory and proapoptotic effect on cervical cancer SiHa cells, and enhances the chemosensitivity to cisplatin. [4]
In vivo試験
臨床試験
特集 An Aurora selective ATP-competitive inhibitor.

推薦された実験操作 (公開の文献だけ)

キナーゼアッセイ: [1]

In vitro kinase assays Recombinant Aurora A and B are expressed as NH2-terminal His6-tagged fusion proteins using a baculovirus expression system. Aurora A is purified by affinity chromatography using Ni-NTA agarose, and Aurora B is purified by ion exchange chromatography using CM Sepharose Fast Flow. 1 ng purified recombinant enzyme is added to a reaction cocktail containing 25 mM Tris-HCl, pH 7.5, 12.5 mM KCl, 2.5 mM NaF, 0.6 mM DTT, 6.25 mM MnCl2, 10 μM peptide substrate, 10 μM for Aurora A or 5 μM ATP for Aurora B, and 0.2 μCi γ-[33P]ATP (specific activity ≥2,500 Ci/mmol), and is then incubated at RT for 60 minutes. Reactions are stopped by addition of 20% phosphoric acid, and the products are captured on P30 nitrocellulose filters and assayed for incorporation of 33P with a BetaplateTM counter. No enzyme and no compound control values are used to determine the concentration of ZM447439, which gave 50% inhibition of enzyme activity. Further details are available on request from Nicholas Keen.

細胞アッセイ: [2]

細胞系 BON, QGP-1 and MIP-101 cells
濃度 0-5 μM
処理時間 72 hours
方法 Cell number is evaluated by crystal violet staining. In brief, cells in 96-well plates are fixed with 1% glutaraldehyde. Then cells are stained with 0.1% crystal violet. The unbound dye is removed by washing with water. Bound crystal violet is solubilized with 0.2% Triton X-100. Light extinction which increases linearly with the cell number is analyzed at 570 nm using an ELISA reader.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesBaboonDogMonkeyRabbitGuinea pigRatHamsterMouse
Weight (kg)121031.80.40.150.080.02
Body Surface Area (m2)0.60.50.240.150.050.0250.020.007
Km factor202012128653
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

参考

化学情報

Download ZM 447439 SDF
分子量 513.59
化学式

C29H31N5O4

CAS No. 331771-20-1
保管 2年-20℃
6月-80℃in DMSO
別名
溶解度 (25°C) * In vitro DMSO 103 mg/mL (200.54 mM)
<1 mg/mL (<1 mM)
エタノール <1 mg/mL (<1 mM)
In vivo 30% PEG400/0.5% Tween80/5% propylene glycol 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 N-(4-(6-methoxy-7-(3-morpholinopropoxy)quinazolin-4-ylamino)phenyl)benzamide

研究分野

カスタマーレビュー (3)


Click to enlarge
Rating
Source Mol Biol Cell, 2011, 22, 4227-35. ZM 447439 purchased from Selleck
Method Flow cytometry
Cell Lines HeLa Tet-on cells
Concentrations
Incubation Time 0-1 h
Results p31comet depletion did not block mitotic exit induced by Aurora B inhibitor ZM447439.

Click to enlarge
Rating
Source Dr. Yuanhong Chen of University of Nebraska. ZM 447439 purchased from Selleck
Method Western blot
Cell Lines HeLa cells
Concentrations 1 μM
Incubation Time 2 h
Results The results showed that ZM447439 inhibits both Aurora-B and –C kinases, but not Aurora-A kinase.

Click to enlarge
Rating
Source Dr. Zhang of Tianjin Medical University. ZM 447439 purchased from Selleck
Method Western blot
Cell Lines
Concentrations 0-10 μM
Incubation Time
Results ZM447439 treatment resulted in a reduction of Histone H3 and Aurora A/B/C phosphorylation.

製品表彰状 (9)

技術サポート&よくある質問(FAQ)

顧客がするかもしれない質問に対する答えは、指示を取り扱っている阻害剤で見つかります。話題は、貯蔵液(阻害剤と特別な注意を細胞ベースの分析法と動物のために必要とする問題を保存することは実験します)を準備する方法を含みます。

電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)

他の問い合わせをするならば、メッセージを残してください。

* 必須

Related オーロラ・キナーゼ 阻害剤

  • MK-8745

    MK-8745 is a potent and selective Aurora A inhibitor with IC50 of 0.6 nM, more than 450-fold selectivity for Aurora A over Aurora B.

  • LEE011

    LEE011 is an orally available, and highly specific CDK4/6 inhibitor.

  • K-Ras(G12C) inhibitor 6

    K-Ras(G12C) inhibitor 6 is an allosteric, and selective inhibitor of oncogenic K-Ras(G12C).

  • EHT 1864

    EHT 1864 is a potent Rac family GTPase inhibitor with Kd of 40 nM, 50 nM, 60 nM and 250 nM for Rac1, Rac1b, Rac2 and Rac3, respectively.

  • Alisertib (MLN8237)

    Alisertib (MLN8237)は、1.2nMのIC50による選択的なオーロラA阻害剤です。

    Features:MLN8237 是第一个口服有效的小分子Aurora A激酶选择性抑制剂。

  • Barasertib (AZD1152-HQPA)

    Barasertib (AZD1152-HQPA)は、0.37nMのIC50による非常に選択的なオーロラB阻害剤です。

  • VX-680 (Tozasertib, MK-0457)

    VX-680 (Tozasertib, MK-0457)は汎オーロラ・キナーゼ(AK)阻害剤、、オーロラA、オーロラBとオーロラCに作用すると、 Kiapp がそれぞれ 0.6 nM、18 nM 、 4.6 nMになる。

  • MLN8054

    MLN8054は、4nMのIC50によるオーロラAキナーゼの強力で選択的な阻害剤です。

    Features:MLN8054是有效的 Aurora A激酶选择性抑制剂。

  • Aurora A Inhibitor I

    Aurora A Inhibitor I阻害剤IはAurora A選択阻害剤、IC50が3.4nM。

    Features:Aurora A Inhibitor I 是2,4-二苯胺嘧啶抑制剂。

最近見られたアイテム

Tags: ZM 447439を買う | ZM 447439供給者 | ZM 447439を購入する | ZM 447439費用 | ZM 447439生産者 | オーダーZM 447439 | ZM 447439代理店
お問い合わせ